Cargando…

Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells

Hepatic fibrosis is concomitant with sinusoidal pathological angiogenesis, which has been highlighted as novel therapeutic targets for the treatment of chronic liver disease. Our prior studies have demonstrated that curcumin has potent antifibrotic activity, but the mechanisms remain to be elucidate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Feng, Zhang, Zili, Chen, Li, Kong, Desong, Zhang, Xiaoping, Lu, Chunfeng, Lu, Yin, Zheng, Shizhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124023/ https://www.ncbi.nlm.nih.gov/pubmed/24779927 http://dx.doi.org/10.1111/jcmm.12286

Ejemplares similares

Curcumin blunts epithelial-mesenchymal transition of hepatocytes to alleviate hepatic fibrosis through regulating oxidative stress and autophagy
por: Kong, Desong, et al.
Publicado: (2020)

The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells
por: Zhang, Zili, et al.
Publicado: (2020)

Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress
por: Lin, Jianguo, et al.
Publicado: (2009)

Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF
por: Shao, Shan, et al.
Publicado: (2019)

Curcumol attenuates liver sinusoidal endothelial cell angiogenesis via regulating Glis‐PROX1‐HIF‐1α in liver fibrosis
por: Yang, Xiang, et al.
Publicado: (2020)

Curcumol alleviates liver fibrosis by inducing endoplasmic reticulum stress-mediated necroptosis of hepatic stellate cells through Sirt1/NICD pathway
por: Sun, Sumin, et al.
Publicado: (2022)

Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis
por: Chen, Li, et al.
Publicado: (2022)

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013)

Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1α/NF-κB feedback pathway to inhibit liver fibrosis
por: Wang, Feixia, et al.
Publicado: (2022)

Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
por: Wu, Mei, et al.
Publicado: (2020)

Tetrahydropalmatine attenuates liver fibrosis by suppressing endoplasmic reticulum stress in hepatic stellate cells
por: Xuan, Yuanyuan, et al.
Publicado: (2022)

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
por: Yin, Xiaochun, et al.
Publicado: (2022)

Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING Pathway
por: Chen, Li, et al.
Publicado: (2023)

N(6)-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells
por: Shen, Min, et al.
Publicado: (2021)

MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression
por: Wang, Qi, et al.
Publicado: (2020)

Hepatic stellate cells specific liposomes with the Toll‐like receptor 4 shRNA attenuates liver fibrosis
por: Zhang, Yuwei, et al.
Publicado: (2020)

Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis
por: Zhao, Xue-Ke, et al.
Publicado: (2017)

Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis
por: Feng, Jiao, et al.
Publicado: (2019)

Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells
por: Chen, Ling, et al.
Publicado: (2015)

Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells
por: Park, Yong Joo, et al.
Publicado: (2020)

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression
por: Ye, Bingyu, et al.
Publicado: (2023)

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
por: Pu, Shiyun, et al.
Publicado: (2021)

Hepatic stellate cells and parasite-induced liver fibrosis
por: Anthony, Barrie, et al.
Publicado: (2010)

Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
por: Khomich, Olga, et al.
Publicado: (2019)

Crosstalk between NK cells and hepatic stellate cells in liver fibrosis
por: Zhang, Yang, et al.
Publicado: (2022)

Human Menstrual Blood‐Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators
por: Chen, Lijun, et al.
Publicado: (2016)

Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell
por: Zhang, Zili, et al.
Publicado: (2016)

SNS-032 attenuates liver fibrosis by anti-active hepatic stellate cells via inhibition of cyclin dependent kinase 9
por: He, Xiao-Li, et al.
Publicado: (2022)

Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver Fibrosis
por: Li, Zhiman, et al.
Publicado: (2021)

Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways
por: Li, Zhiyong, et al.
Publicado: (2021)

Ivermectin Attenuates CCl(4)-Induced Liver Fibrosis in Mice by Suppressing Hepatic Stellate Cell Activation
por: Ying, Hanglu, et al.
Publicado: (2022)

Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease
por: Li, Xi, et al.
Publicado: (2017)

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells
por: Feng, Yi, et al.
Publicado: (2016)

Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
por: Kitano, Mio, et al.
Publicado: (2016)

Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis
por: Cho, Eun-Hee
Publicado: (2018)

Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis
por: Hoffmann, Céline, et al.
Publicado: (2020)

Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2022)

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
por: Zhang, Chong-Yang, et al.
Publicado: (2016)

Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway
por: Mu, Mao, et al.
Publicado: (2018)

Ferulic Acid Combined With Bone Marrow Mesenchymal Stem Cells Attenuates the Activation of Hepatic Stellate Cells and Alleviates Liver Fibrosis
por: Zhang, Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1mc2u1a9pokfd9nev3kgpfaf0h